Portage Biotech Inc. (PRTG)
NASDAQ: PRTG · Real-Time Price · USD
4.140
-0.360 (-8.00%)
Mar 3, 2025, 4:00 PM EST - Market closed
Portage Biotech Employees
Portage Biotech had 7 employees as of March 31, 2024. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$9,611,143
Market Cap
4.64M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 7 | 0 | - |
| Mar 31, 2023 | 7 | 1 | 16.67% |
| Mar 31, 2022 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
PRTG News
- 19 days ago - Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements - GlobeNewsWire
- 4 weeks ago - Portage Biotech Announces Completion of $2.15 Million Private Financing - GlobeNewsWire
- 2 months ago - Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company - GlobeNewsWire
- 2 months ago - Portage Biotech Announces Receipt of Nasdaq Noncompliance Letter - GlobeNewsWire
- 3 months ago - Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024 - GlobeNewsWire
- 11 months ago - Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives - GlobeNewsWire
- 1 year ago - Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares - GlobeNewsWire
- 1 year ago - Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update - GlobeNewsWire